3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
3863
Neoplasms
2988
Prostatic Neoplasms
1754
Colorectal Neoplasms
1430
Lung Neoplasms
1331
Motor Activity
805
Head and Neck Neoplasms
686
Pancreatic Neoplasms
663
Colonic Neoplasms
655
Uterine Cervical Neoplasms
653
Carcinoma, Non-Small-Cell Lung
631
Carcinoma, Hepatocellular
631
Rectal Neoplasms
571
Stomach Neoplasms
547
Brain Neoplasms
484
Ovarian Neoplasms
441
Anxiety Disorders
420
Pain
419
Neoplasm Metastasis
385
Esophageal Neoplasms
384
Polycystic Ovary Syndrome
374
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Urinary Bladder Neoplasms
351
Fatigue
340
Melanoma
323
Multiple Myeloma
322
Lymphoma
306
Depression
306
Endometrial Neoplasms
290
Liver Neoplasms
279
Interventions
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Interventional
×
Embolism and Thrombosis
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled
NCT04304651
2024-12-16
MVTEP2/SOME2
University Hospital, Brest
Phase NA
Recruiting
1,276 enrolled